Novavax (NVAX)
(Delayed Data from NSDQ)
$13.11 USD
+4.23 (47.64%)
Updated May 13, 2024 04:00 PM ET
After-Market: $13.19 +0.08 (0.61%) 5:32 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -0.80 |
EPS Last Quarter | -1.05 |
Last EPS Surprise | -0.96% |
ABR | 2.00 |
Earnings ESP
|
33.58% |
---|---|
Current Year | -0.82 |
Next Year | -0.06 |
EPS (TTM) | -3.17 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 101.73M | 78.66M | NA | 1.03B |
# of Estimates | 4 | 5 | NA | 5 |
High Estimate | 152.00M | 103.70M | NA | 1.61B |
Low Estimate | 75.00M | 52.00M | NA | 634.70M |
Year ago Sales | 424.43M | 186.99M | 983.71M | NA |
Year over Year Growth Est. | -76.03% | -57.93% | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.80 | -0.80 | -0.82 | -0.06 |
# of Estimates | 5 | 5 | 7 | 7 |
Most Recent Consensus | -0.93 | -0.92 | -1.40 | -0.16 |
High Estimate | -0.53 | -0.58 | 0.13 | 1.66 |
Low Estimate | -1.23 | -1.06 | -1.59 | -1.23 |
Year ago EPS | 0.58 | -1.26 | -5.41 | -0.82 |
Year over Year Growth Est. | -237.93% | 36.51% | 84.84% | 93.03% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 2 | 1 |
Up Last 60 Days | 2 | 1 | 3 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 1 |
Down Last 60 Days | 0 | 1 | 1 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.80 | -0.80 | -0.82 | -0.06 |
7 Days Ago | -0.80 | -0.80 | -0.82 | -0.06 |
30 Days Ago | -0.83 | -0.85 | -0.88 | 0.08 |
60 Days Ago | -0.85 | -0.65 | -0.79 | 0.34 |
90 Days Ago | -1.14 | -0.52 | -0.69 | 0.20 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.53 | -1.05 | -1.38 | 0.46 |
Zacks Consensus Estimate | -0.80 | -0.80 | -0.82 | -0.06 |
Earnings ESP | 33.58% | -30.92% | -68.29% | 905.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.05 | -1.44 | -1.26 | 0.58 | NA |
Estimate | -1.04 | -0.49 | -1.82 | -1.24 | NA |
Difference | -0.01 | -0.95 | 0.56 | 1.82 | 0.36 |
Surprise | -0.96% | -193.88% | 30.77% | 146.77% | -4.33% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more